Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

XORTX THERAPEUTICS INC. (XRTX)

  • Technical Exchange News
  • April 02, 2026, 07:36 UTC
  • 7
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: XORTX Therapeutics Inc. - Common Stock. New value: XORTX Therapeutics Inc. - Common Shares.

Comment Full text

TTD attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:54 UTC
  • 7
  • 0 comments

TTD attributes changed: Attr: Fin_status N -> D;

Comment Full text

STFS attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:54 UTC
  • 9
  • 0 comments

STFS attributes changed: Attr: Fin_status D -> N;

Comment Full text

INVZ attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:52 UTC
  • 5
  • 0 comments

INVZ attributes changed: Attr: Fin_status N -> D;

Comment Full text

GNLN attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:52 UTC
  • 6
  • 0 comments

GNLN attributes changed: Attr: Fin_status N -> D;

Comment Full text

ELPW attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:52 UTC
  • 6
  • 0 comments

ELPW attributes changed: Attr: Fin_status D -> N;

Comment Full text

AZ attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:51 UTC
  • 10
  • 0 comments

AZ attributes changed: Attr: Fin_status D -> N;

Comment Full text

ADTX attributes changed

  • Technical Exchange News
  • April 02, 2026, 01:51 UTC
  • 11
  • 0 comments

ADTX attributes changed: Attr: Fin_status D -> N;

Comment Full text

ADITXT, INC. (ADTX)

  • Technical Exchange News
  • April 02, 2026, 01:51 UTC
  • 8
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ADITXT, INC. (ADTX)

  • Technical Exchange News
  • April 02, 2026, 01:51 UTC
  • 9
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 64
  • 65
  • 66
  • 67
  • 68
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(266832)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155565)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin